RE:RE:RE:RE:RE:RE:NSU P/E Ratio At 56 Times EarningsLet's not forget all the Pharmaceutical companies that might get FDA approval on some miracle drug. Maybe it will happen, maybe it wont. What's that worth? Fact is NSU has Price and Earnings, and its share price is valuated at 56 times earnings. That makes NSU very expensive. It may hit a home run, or it may go broke trying. Anyone can choose to ignore the p/e ratio for whatever reason. Its a legitimate question & concern!!!